JP2010521495A5 - - Google Patents

Download PDF

Info

Publication number
JP2010521495A5
JP2010521495A5 JP2009553828A JP2009553828A JP2010521495A5 JP 2010521495 A5 JP2010521495 A5 JP 2010521495A5 JP 2009553828 A JP2009553828 A JP 2009553828A JP 2009553828 A JP2009553828 A JP 2009553828A JP 2010521495 A5 JP2010521495 A5 JP 2010521495A5
Authority
JP
Japan
Prior art keywords
formulation
xaa
self
amino acid
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009553828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010521495A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/057104 external-priority patent/WO2008113030A2/en
Publication of JP2010521495A publication Critical patent/JP2010521495A/ja
Publication of JP2010521495A5 publication Critical patent/JP2010521495A5/ja
Withdrawn legal-status Critical Current

Links

JP2009553828A 2007-03-14 2008-03-14 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強 Withdrawn JP2010521495A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89487207P 2007-03-14 2007-03-14
PCT/US2008/057104 WO2008113030A2 (en) 2007-03-14 2008-03-14 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013133118A Division JP5860437B2 (ja) 2007-03-14 2013-06-25 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強

Publications (2)

Publication Number Publication Date
JP2010521495A JP2010521495A (ja) 2010-06-24
JP2010521495A5 true JP2010521495A5 (OSRAM) 2011-04-28

Family

ID=39462068

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009553828A Withdrawn JP2010521495A (ja) 2007-03-14 2008-03-14 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強
JP2013133118A Expired - Fee Related JP5860437B2 (ja) 2007-03-14 2013-06-25 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強
JP2014227726A Expired - Fee Related JP6112621B2 (ja) 2007-03-14 2014-11-10 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強
JP2017043479A Pending JP2017105833A (ja) 2007-03-14 2017-03-08 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013133118A Expired - Fee Related JP5860437B2 (ja) 2007-03-14 2013-06-25 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強
JP2014227726A Expired - Fee Related JP6112621B2 (ja) 2007-03-14 2014-11-10 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強
JP2017043479A Pending JP2017105833A (ja) 2007-03-14 2017-03-08 漏出性または損傷を受けたタイトジャンクションの処置および細胞外マトリクスの増強

Country Status (7)

Country Link
US (2) US9415084B2 (OSRAM)
EP (1) EP2146733B1 (OSRAM)
JP (4) JP2010521495A (OSRAM)
CA (1) CA2680824C (OSRAM)
DK (1) DK2146733T3 (OSRAM)
ES (1) ES2854674T3 (OSRAM)
WO (1) WO2008113030A2 (OSRAM)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080007380A (ko) 2005-04-25 2008-01-18 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및방법
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
US8143042B2 (en) 2006-01-12 2012-03-27 Massachusetts Institute Of Technology Biodegradable elastomers
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2638823A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
KR20110091019A (ko) 2006-04-25 2011-08-10 메사추세츠 인스티튜트 오브 테크놀로지 오염물, 체액 또는 다른 실재물의 이동 및/또는 다른 생리학적 상태에 영향을 주기 위한 조성물 및 방법
WO2009046844A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic uses of peptide tdvngdgrhdl
WO2009049742A2 (en) * 2007-09-11 2009-04-23 Mondobiotech Laboratories Ag Use of melanotrophin-potentiating factor as a therapeutic agent
WO2009046831A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
CN102170919A (zh) 2008-10-06 2011-08-31 三维肽胶株式会社 组织闭塞剂
US20110200560A1 (en) * 2009-05-26 2011-08-18 Massachusetts Institute Of Technology Non-ionic self-assembling peptides and uses thereof
US9084752B2 (en) * 2009-12-14 2015-07-21 The University Of Hong Kong Compositions and methods for controlling proliferation and differentiation of cells
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
US20110143993A1 (en) * 2009-12-15 2011-06-16 The Brigham And Women's Hospital, Inc. Endothelial basement membrane targeting peptide ligands
WO2012008967A1 (en) * 2010-07-16 2012-01-19 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US8741833B2 (en) * 2010-07-16 2014-06-03 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
WO2012048268A2 (en) * 2010-10-07 2012-04-12 Massachusetts Instiute Of Technology Delivery of a solid body and/or a fluid using a linear lorentz-force actuated needle-free jet injection system
US8546338B2 (en) 2010-12-08 2013-10-01 Johnson & Johnson Consumer Companies, Inc. Self-assembling hydrogels based on dicephalic peptide amphiphiles
EP2654793B1 (en) 2010-12-21 2017-09-13 Leidos, Inc. Methods and compositions for wound treatment
EP3466964A1 (en) 2012-07-06 2019-04-10 3-D Matrix Ltd. Fill-finish process for peptide solutions
CA2928851A1 (en) 2012-07-19 2014-01-23 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
EP2698162A1 (en) 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion
US9241891B2 (en) * 2012-10-30 2016-01-26 The Procter & Gamble Company Personal care compositions comprising self-assembling peptides
CN105408346B (zh) 2013-03-30 2019-05-03 株式会社糖锁工学研究所 糖链-多肽复合物
AU2014308597B2 (en) 2013-08-22 2017-01-19 Arch Biosurgery, Inc. Implantable meshes for controlling the movement of fluids
ES2669548T3 (es) 2013-09-25 2018-05-28 Credentis Ag Producto de cuidado dental para el blanqueamiento de los dientes
EP2853256A1 (en) 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
WO2015053338A1 (ja) * 2013-10-08 2015-04-16 学校法人東京理科大学 カチオン性ペプチドおよびそれを含む医薬組成物
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
EP3628337B1 (en) 2014-03-10 2025-05-28 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
CN117138022A (zh) 2014-03-10 2023-12-01 三维矩阵有限责任公司 自组装肽组合物
CN106659821A (zh) * 2014-03-28 2017-05-10 大塚化学株式会社 止血用药物组合物
AU2016374425B2 (en) * 2015-12-18 2021-10-21 3-D Matrix, Ltd. Hemostatic composition and hemostatic method using hemostatic composition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
EP3248591A1 (en) 2016-05-24 2017-11-29 Credentis AG Method and product for caries treatment
EP3248590A1 (en) 2016-05-24 2017-11-29 Credentis AG Personal dental care product for caries treatment
WO2019040528A1 (en) * 2017-08-22 2019-02-28 The Board Of Trustees Of The Leland Stanford Junior University BIOMATERIALS INCORPORATED WITH ELAFINE FOR THE TREATMENT OF CHRONIC TISSUE ULCERS
JP2021506815A (ja) 2017-12-15 2021-02-22 株式会社スリー・ディー・マトリックス 界面活性ペプチドナノ構造および薬物送達における使用
CN111867616A (zh) * 2018-01-11 2020-10-30 国立大学法人东京大学 Ntcp抑制剂
EP3768295A1 (en) 2018-03-23 2021-01-27 Arch Biosurgery, Inc. Sap and peptidomimetic compositions for reducing symptoms of inflammation
US20190292223A1 (en) 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetics for treatment of eye disease
CN113194976A (zh) * 2018-10-05 2021-07-30 学校法人久留米大学 用于肠道中的溃疡或瘘管的治疗或预防的医药组合物
CA3140207C (en) 2019-06-13 2025-05-13 Hollister Inc REUSABLE URINARY CATHETER-TYPE PRODUCTS
WO2020263859A1 (en) 2019-06-25 2020-12-30 Hollister Incorporated Reusable urinary catheter products
EP3831360A1 (en) 2019-12-04 2021-06-09 Credentis AG Personal dental care product for preventing demineralisation
CN111116717B (zh) * 2020-01-03 2021-10-29 中国科学院大学温州研究院(温州生物材料与工程研究所) 含有n-甲基-d-葡糖胺单元的糖肽水凝胶、制备方法及其应用
EP4090350A1 (en) 2020-01-13 2022-11-23 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
EP4291219A4 (en) * 2021-02-10 2024-12-25 3-D Matrix, Ltd. Pharmaceutical composition containing specific self-assembling peptide rada16 for treating or preventing lower gastrointestinal diseases such as inflammatory bowel disease
JPWO2024128081A1 (OSRAM) * 2022-12-16 2024-06-20
CN116789854B (zh) * 2023-06-08 2024-04-02 东北农业大学 兼具细菌捕获与抑菌功能的纳米抗菌肽及制备方法和应用
WO2025226888A1 (en) * 2024-04-26 2025-10-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Ecm-derived injectable embolic for permanent treatment of cerebral aneurysms

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098728A (en) * 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4211227A (en) * 1978-07-03 1980-07-08 The Kendall Company Surgical sponge material
US4272398A (en) * 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US4636208A (en) * 1984-10-05 1987-01-13 Ewald Rath Surgical sponge
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US5019646A (en) 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
EP0609212A4 (en) * 1989-12-04 1995-04-19 Kensey Nash Corp PLUG DEVICE FOR SEALING OPENINGS AND METHOD FOR USE.
US5180375A (en) * 1991-05-02 1993-01-19 Feibus Miriam H Woven surgical drain and woven surgical sponge
US5222974A (en) * 1991-11-08 1993-06-29 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5645565A (en) * 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
WO1999052574A1 (en) 1998-04-10 1999-10-21 Massachusetts Institute Of Technology Biopolymers resistant coatings
WO2000041732A1 (en) * 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
WO2000063079A1 (en) * 1999-04-15 2000-10-26 Ultracell Medical Technologies Of Connecticut, Inc. Method for producing surgical sponge device and product thereof
US6844324B1 (en) * 1999-11-12 2005-01-18 Massachusetts Institute Of Technology Modular peptide mediated intracellular delivery system and uses therefore
US6953659B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of nucleic acids
US6953656B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of polypeptides
US6846319B2 (en) * 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
ATE419333T1 (de) 2001-02-06 2009-01-15 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2003006043A1 (en) 2001-07-10 2003-01-23 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
US20060199778A1 (en) * 2001-09-19 2006-09-07 Rutledge Ellis-Behnke Methods and products related to non-viral transfection
WO2003084980A2 (en) 2002-04-02 2003-10-16 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
US20040242469A1 (en) * 2002-05-13 2004-12-02 Lee Richard T. Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
CA2387257C (en) * 2002-05-23 2009-07-28 Suncor Energy Inc. Static deaeration conditioner for processing of bitumen froth
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
WO2004013161A2 (en) 2002-08-06 2004-02-12 Epix Pharmaceuticals, Inc. Peptide aggregates
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
EP2711025A3 (en) * 2003-06-25 2014-09-10 Massachusetts Institute of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US7846891B2 (en) * 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
GB0413346D0 (en) 2004-06-15 2004-07-21 Theryte Ltd Treating cancer
EP4023240A1 (en) 2004-07-06 2022-07-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
WO2006047315A2 (en) * 2004-10-25 2006-05-04 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
US7429567B2 (en) * 2005-01-04 2008-09-30 The Brigham And Women's Hospital, Inc. Sustained delivery of PDGF using self-assembling peptide nanofibers
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20080007380A (ko) 2005-04-25 2008-01-18 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및방법
KR20110091019A (ko) * 2006-04-25 2011-08-10 메사추세츠 인스티튜트 오브 테크놀로지 오염물, 체액 또는 다른 실재물의 이동 및/또는 다른 생리학적 상태에 영향을 주기 위한 조성물 및 방법
US20070287741A1 (en) * 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
US20120085262A1 (en) 2010-08-26 2012-04-12 Freudenberg Forschungsdienste Kg Production of Highly Concentrated Solutions of Self-Assembling Proteins

Similar Documents

Publication Publication Date Title
JP2010521495A5 (OSRAM)
JP7333425B2 (ja) 精製された両親媒性ペプチド組成物を用いた、外科的方法
ES2673947T3 (es) Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
CN101267831B (zh) 用于促进止血和其它生理活动的组合物和方法
JP6478927B2 (ja) 消化管閉塞の予防のための材料
US20170252479A1 (en) Biocompatible hemostatic product and preparation method thereof
JP6461096B2 (ja) 結腸切除なしに炎症性腸疾患を処置するための方法および組成物
KR20170088366A (ko) 혈소판 풍부 혈장(prp) 또는 골수 농축물(bmc)을 단독으로 혹은 히알루론산과 결합하여 조제하기 위한 새로운 표준화 및 의료장비
JP7378486B2 (ja) 医療用接着剤及びその調製方法、その用途
CN114903845A (zh) 用于清除碎石取石术后残留结石碎块的凝胶组合物
CN111298188A (zh) 自固化双组分离子和温度双敏感型消化道粘膜保护胶及其应用
WO2016080158A1 (ja) 創傷治癒を促進し生体諸臓器の被覆（コーチング）及び庇護を目的とした生体皮膜剤
EP4090350A1 (en) Self-assembling peptide gel formulation and methods of use
RU2093093C1 (ru) Способ лечения глубоких отморожений пальцев кисти
RU2499573C1 (ru) Способ лечения карбункулов почки
KR20220169912A (ko) 콜레스테릭 액정 및 탄닌산을 포함하는 광학 활성 지혈제 조성물 및 이의 제조방법
CN120939239A (zh) 用于鸡眼清除术后的足部创面护理药物、制作方法及足部创面护理贴
HK1132469A (en) Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions
HK1155356A (en) Compositions and methods for promoting hemostasis and other physiological activities